AI Assistant
Blog
Pricing
Log In
Sign Up
A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.